Literature DB >> 15013874

Choroidal neovascularization.

Hans E Grossniklaus1, W Richard Green.   

Abstract

PURPOSE: To review clinicopathologic findings of choroidal neovascularization (CNV) in a historical framework with emphasis on pathobiology and correlation with treatment.
DESIGN: Selective literature review combined with authors' experience.
RESULTS: Choroidal neovascularization represents a stereotypic, nonspecific response to a specific stimulus. Although CNV differs among patients, the general growth patterns are subretinal pigment epithelium (type 1), subretinal (type 2), or combined. Choroidal neovascularization occurs over time in dynamic stages of initiation, active and involutional. Treatments are now being designed based on modern understanding of CNV growth.
CONCLUSIONS: Progress continues to be made concerning understanding the pathobiology and treatment of CNV.

Entities:  

Mesh:

Year:  2004        PMID: 15013874     DOI: 10.1016/j.ajo.2003.09.042

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  147 in total

Review 1.  Enhanced depth imaging-OCT of the choroid: a review of the current literature.

Authors:  H Laviers; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

2.  A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions.

Authors:  Hui-Yuan Hou; Hong-Liang Liang; Yu-Sheng Wang; Zhao-Xia Zhang; Bai-Ren Wang; Yuan-Yuan Shi; Xiao Dong; Yan Cai
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

3.  The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.

Authors:  Y Wang; V M Wang; C-C Chan
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

4.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Amy L Wong; David T L Liu; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

5.  Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography.

Authors:  Jin Yang; Qinqin Zhang; Elie H Motulsky; Marie Thulliez; Yingying Shi; Cancan Lyu; Luis de Sisternes; Mary K Durbin; William Feuer; Ruikang K Wang; Giovanni Gregori; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2019-06-21       Impact factor: 5.258

6.  Adhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation study.

Authors:  Abbas Shirinifard; James Alexander Glazier; Maciej Swat; J Scott Gens; Fereydoon Family; Yi Jiang; Hans E Grossniklaus
Journal:  PLoS Comput Biol       Date:  2012-05-03       Impact factor: 4.475

7.  Quantitative optical coherence tomography findings in various subtypes of neovascular age-related macular degeneration.

Authors:  Sandra Liakopoulos; Sharel Ongchin; Alok Bansal; Sandeep Msutta; Alexander C Walsh; Paul G Updike; Srinivas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

8.  Lentivirus vector-mediated knockdown of erythropoietin-producing hepatocellular carcinoma receptors B4 inhibits laser-induced choroidal neovascularization.

Authors:  Jing Du; Wei Zhao; Yusheng Wang; Yan Cai
Journal:  J Ocul Pharmacol Ther       Date:  2012-10-04       Impact factor: 2.671

9.  Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

Authors:  G Malek; L V Johnson; B E Mace; P Saloupis; D E Schmechel; D W Rickman; C A Toth; P M Sullivan; C Bowes Rickman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-03       Impact factor: 11.205

10.  Ocular cytomegalovirus latency exacerbates the development of choroidal neovascularization.

Authors:  Jinxian Xu; Xinglou Liu; Xinyan Zhang; Brendan Marshall; Zheng Dong; Yutao Liu; Diego G Espinosa-Heidmann; Ming Zhang
Journal:  J Pathol       Date:  2020-05-21       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.